Adlai Nortye ANL
NASDAQ ANL
$15.09 -0.67 (-4.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Short-term Investments (2023 - 2026)

Updated

Adlai Nortye's Short-term Investments came in at -$33.29 million for Q2 2026.

Analysis

Adlai Nortye (ANL) Short-term Investments (2023 - 2026) Analysis & Trends

At the end of FY2023, Adlai Nortye's Short-term Investments was -$84.49 million.

  • The Q2 2026 figure represents the lowest quarterly Short-term Investments since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Adlai Nortye 518.14 Mn 418.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -33.29 Mn
Dec 31, 2023 -84.49 Mn
API Access

Adlai Nortye Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ANL&period=max&api_key=YOUR_API_KEY